EXSTEM
Live / Registered — Registered (as of 13 Jan 2026)
What this means for you
Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79421680
- Registration number
- 8097995
- Mark type
- Stylized text
- Filed
- 20 Feb 2025
- Published for opposition
- 25 Nov 2025
- Registered
- 13 Jan 2026
- Attorney of record
- Laura K. Pitts
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Cosmetic creams for genital use for improving male menopause disorder other than for medical purposes; Cosmetic creams for genital use for improving male sexual function other than for medical purposes; Cosmetic creams for genital use for improving erectile function other than for medical purposes; Cosmetics
- Class 005 — Pharmaceuticals: Medicated skin care preparations, namely, creams for genital use for improving male menopause disorder for medical purposes; Medicated skin care preparations, namely, creams for genital use for improving male sexual function for medical purposes; Medicated skin care preparations, namely, creams for genital use for improving erectile function for medical purposes
Owner
- PC Medical Inc., Tokyo 113-0034, JP
- PC Medical Inc., Tokyo 113-0034, JP
- PC Medical Inc., JP
Prosecution history
- 13 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Oct 2025 — REFUSAL PROCESSED BY IB
- 14 Sept 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 14 Sept 2025 — REFUSAL PROCESSED BY MPU
- 05 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 04 Aug 2025 — NON-FINAL ACTION WRITTEN
- 25 Jul 2025 — ASSIGNED TO EXAMINER